Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Levels of soluble adhesion molecules have been shown to reflect their cell surface expression in vitro, and thus may provide a useful surrogate marker of surface expression at inflammatory sites. In patients with SLE and vasculitis, serum levels of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-Selection were determined by ELISA during different stages of disease activity. Levels of soluble(s) VCAM-1 correlated with disease activity in patients with SLE, being significantly higher during active compared with inactive disease (P = 0.003), and normalizing with clinical remission. By contrast, in patients with vasculitis, although sVCAM-1 levels were elevated in active disease, they fell but did not normalize in inactive disease, suggesting that treatment may be suppressing the clinical manifestations rather than targeting the underlying pathogenic mechanism. Soluble ICAM-1 and E-Selectin levels did not relfect disease activity in either SLE or vasculitis.

Original publication

DOI

10.1093/rheumatology/33.12.1112

Type

Journal article

Journal

Br j rheumatol

Publication Date

12/1994

Volume

33

Pages

1112 - 1116

Keywords

Adolescent, Adult, Aged, Biomarkers, Cell Adhesion Molecules, Cross-Sectional Studies, E-Selectin, Enzyme-Linked Immunosorbent Assay, Female, Humans, Intercellular Adhesion Molecule-1, Lupus Erythematosus, Systemic, Male, Middle Aged, Severity of Illness Index, Vascular Cell Adhesion Molecule-1, Vasculitis